Compounded Semaglutide Risks vs CFP Protocol for Post-Bariatric Patients

Compounded Semaglutide Risks vs CFP Protocol for Post-Bariatric Patients Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring Compounded Semaglutide Risks vs CFP Protocol for Post-Bariatric Patients. ... Take a breath, settle in, and let's walk through this together — clearly, calmly, and based on what the evidence actually shows. ... We'll touch on compounded semaglutide, Clark Protocol, post-bariatric — especially as they apply to real people over forty. ... Post-bariatric patients face unique metabolic challenges after procedures like gastric bypass or sleeve gastrectomy. Rapid weight loss often leads to muscle wasting, nutrient malabsorption, and altered gut signaling. While GLP-1 medications like semaglutide offer powerful appetite control, the choice between compounded versions and structured cycling protocols such as the Clark Protocol (CFP) determines long-term success. This comparison examines the hidden dangers of compounded semaglutide against the evidence-based, cycling approach of CFP designed specifically for sustained metabolic reset. ... Understanding Compounded Semaglutide and Its Inherent Risks Compounded semaglutide is produced in unregulated pharmacies to bypass shortages and reduce costs. Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/compounded-semaglutide-risks-vs-cfp-protocol-for-post-bariatric-patients-71hulz